Despina Kolivas

Ms. Despina Kolivas

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
BJBernice Rozemai Jooste
Bernice Rozemai Jooste
DKDespina Kolivas
Despina Kolivas
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis
Evidence suggests that low carbohydrate dietary (LCD) approaches can improve glycaemic control and may result in type 2 diabetes mellitus (T2DM) remission. This systematic literature review (SLR) aimed to assess the effectiveness of technology-enabled LCD interventions in the management of people with prediabetes or T2DM. Data sources included Medline, Embase, CINAHL, and Web of Science. Randomised (RCTs) or non-randomised (non-RCTs) controlled trials investigating the effect of technology-enabled LCDs (<130 g/day) or very low carbohydrate diets (VLCDs < 50 g/day) on glycosylated haemoglobin A1c (HbA1c) for at least three months and published in English between 2009 and 2023 were included. Risk of bias assessment, data extraction, and synthesis were conducted using standard tools and procedures. Six studies (two RCTs and four non-RCTs, total sample, n = 1519) were identified and included in the SLR. Two studies examining LCDs reported significant reductions in mean HbA1c (0.4% and −1.2%) and weight loss (−3.8 kg and −7.5 kg) at one year. Three studies examining VLCDs reported significant reductions in mean HbA1c (−0.8% to −1.3%) and weight loss (−12 kg to −14 kg) up to two years. Technology-enabled LCD or VLCD interventions can be a novel approach in helping people with prediabetes or T2DM self-manage their condition and possibly achieve remission. However, further research is required to determine the sustainability, effectiveness, and safety of this approach.

7 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
DKDespina Kolivas
Despina Kolivas
LFLiz Fraser
Liz Fraser
RSRonald Schweitzer
Ronald Schweitzer
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis
Aim: Mobile health (mHealth) applications have been reported to be effective in improving glycaemic control and cardiometabolic health, but mainly as part of shorter-term intervention studies. The aim of this study is to examine the effect of the ongoing Defeat Diabetes mHealth low-carbohydrate diet (LCD) intervention on clinical markers and cardiometabolic risk after 6 months of intervention. Methods: Data were collected via primary care physicians as part of routine T2D monitoring. These included HbA1c (primary outcome), blood pressure, blood lipids, and markers of kidney and liver function. Anthropometrics, as well as changes in the prescription of diabetes, hypertension, and dyslipidaemia medication, were also recorded. Calculated variables, total cholesterol to HDL-c, triglyceride to HDL-c, and waist to height ratios, were analysed to examine changes in cardiometabolic risk profile. Three-day food records were used to assess dietary intake and intervention adherence. Univariate regression models examined changes from baseline to 6 months. Results: Ninety-four participants remained in the study out of the ninety-nine at baseline (mean age 59 ± 11 years, 55 females). After 6 months of intervention, there were significant reductions in HbA1c by −1.0% (95% CI: −1.3 to −0.6), as well as in the liver enzymes ALT (−9.3 U/L 95% CI −16.3 to −2.4) and GGT (−18.8 U/L 95% CI: −31.4 to −6.3) across the cohort. In addition, there was a significant reduction in cardiometabolic risk, as measured by the calculated variables and a decrease in waist circumference (−4.6 cm 95% CI: −8.9 to −0.2). Conclusions: People with T2D receiving LCD education and resources through the Defeat Diabetes mHealth app (version 3.3.8) improved their glycaemic control after 6 months of intervention. Cardiometabolic risk profile and liver function also showed significant improvement. These findings indicate that the use of an LCD digital app is a valuable adjunct in the management of T2D.

8 April 2025 in npj Metabolic Health and Disease
Verified
Journal Article
Open access
PDF file
DKDespina Kolivas
Despina Kolivas
LFLiz Fraser
Liz Fraser
RSRonald Schweitzer
Ronald Schweitzer
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis
Low carbohydrate diets (LCD) have shown efficacy in managing clinical outcomes in type 2 diabetes (T2D). Incorporating digital tools into health care provides an adjunct treatment modality, to educate patients and provide clinical support. This study examines the effect of a mobile health (mHealth) LCD application (app) on glycaemic profile, blood pressure and weight status, in people with T2D. The study is an online single-arm, pre-post study that recruited people with T2D from around Australia, referred via registered supporting general practitioners (GPs). The intervention (Defeat Diabetes app) provides education and resources on the use of a LCD for ongoing management of T2D. After 3 months, our cohort of 99 participants (mean age 59 ± 11 years, 55 females) showed reduced dietary carbohydrate intake as a proportion of overall energy (−14%kJ/day, 95% CI: −17 to −11). Improvement in the primary outcome HbA1c (−1.0%, 95% CI: −1.3 to −0.7), was associated with reduction in dietary carbohydrate intake. Systolic blood pressure (SBP) improved (−6 mmHg, 95% CI: −10 to −1), while 21 participants reduced their diabetes medication dose with two participants discontinuing all diabetes medication. These findings demonstrate that people with T2D receiving LCD education and resources through the Defeat Diabetes app for 3 months improved their glycaemic profile and SBP despite decreased overall medication usage in almost one third of the study sample prescribed medication at baseline.

30 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
DKDespina Kolivas
Despina Kolivas
LFLiz Fraser
Liz Fraser
RSRonald Schweitzer
Ronald Schweitzer
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis
Low-carbohydrate dietary approaches can lead to improvements in blood glucose levels and weight loss, as well as a reduction and/or cessation in medication use in people with type 2 diabetes (T2D). Recent technological advances have led to the development of health-related applications (apps), including a high proportion dedicated to the management of diabetes. The Defeat Diabetes Program is a smartphone- and web-based app that provides guidance on a low-carbohydrate dietary approach for T2D and was designed to be used in conjunction with standard care in the medical management of T2D. The primary aim of this protocol is to provide the rationale and design of a single-arm 12-month pre–post intervention clinical trial using the Defeat Diabetes Program in an Australian community-based cohort of people with T2D who were referred by their general practitioner (GP). The study seeks to engage the GP community to help demonstrate whether the results of using a low-carbohydrate dietary approach for T2D can be achieved by the Defeat Diabetes Program in their patients. This protocol describes (1) the rationale for the selection of primary and secondary outcome measures, (2) the sampling procedures and methodological steps used to identify eligible participants and collect data, and (3) the approach followed to involve and educate GPs to support the trial.

6 March 2026 in International Journal of Behavioral Medicine
Verified
Journal Article
Open access
PDF file
DKDespina Kolivas
Despina Kolivas
LFLiz Fraser
Liz Fraser
RSRonald Schweitzer
Ronald Schweitzer
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis
Background: To examine the 3-month change of a mHealth low-carbohydrate dietary (LCD) application (app) on sleep quality and psychosocial outcomes in people living with type 2 diabetes (T2D). The aim is to understand the broader impact of the LCD app in the Australian primary care context as an adjunct to standard clinical management of T2D. Methods: The single arm pre-post study recruited community-based people living with T2D, with web access from around Australia, referred via registered supporting general practitioners (GPs). Following informed consent, participants obtained access to the Defeat Diabetes app, which provided education and resources on the LCD approach and support for ongoing management of T2D. Participants self-reported dietary data and validated questionnaires assessed sleep quality (B-PSQI), quality of life (QoL) (EQ-5D-5L), diabetes-related distress (PAID-5), and self-efficacy in diabetes self-management (PDSMS). Univariate regression models examined changes from baseline to 3 months. Results: The present study included 99 participants (mean age 59 ± 11 years, 55 females). Mean carbohydrate intake reduced from baseline to 3 months as a proportion of overall energy intake (−14%kJ/day, 95% CI −17 to −11). Self-reported perceived health status (6, 95% CI 1 to 11), self-efficacy (5, 95% CI 4 to 7), and diabetes-related distress scores (−2.0, 95% CI −3 to −1) improved over 3 months, and there were nonsignificant improvements in sleep quality. Conclusion: People with T2D who used a mHealth LCD app significantly improved their perceived health status, diabetes-related distress, and self-efficacy in diabetes self-management scores after 3 months. Practice Implications: mHealth LCD apps should be considered useful adjuncts to current medical management of T2D.

4 November 2025 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
DKDespina Kolivas
Despina Kolivas
LFLiz Fraser
Liz Fraser
RSRonald Schweitzer
Ronald Schweitzer
PBPeter Brukner
Peter Brukner
George MoschonisGeorge Moschonis
George Moschonis